As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, ...

OncoCyte Corporation’s OCX share price has surged by 12.22%, which has investors questioning if this is right time to sell.

The Opentrons Flex neoSwitch Workstation leverages Neochromosome's neoSwitch antibody discovery platform, designed to toggle between yeast surface display for binder selection and protein secretion ...

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Researchers, students and science-lovers across the world now have access to the design of the globally significant SABRE ...

Researchers have developed a light-induced DNA detection method that enables rapid, PCR-free genetic analysis. Their technique offers ultra-sensitive mutation detection in just five minutes, reducing ...

PCR-Machines are based on Polymerase Chain Reaction (PCR) and produce copies of genes exponentially. The PCR cycling reactions are carried out in an automated thermocycler, which is capable of ...

SAN FRANCISCO--(BUSINESS WIRE)--Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic platform against a range of cancer ...

At the same time, ill-fitting lab coats can be a danger in themselves. If they’re too small, they can restrict a scientist’s ...

SAN FRANCISCO--(BUSINESS WIRE)--Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic platform against a range of cancer indications, ...

Nobel laureate David Baker, right, speaks with BioCentury's Simone Fishburn at the Life Science Innovation Northwest ...

Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic platform against a range of cancer indications, emerged from stealth today ...